baber/WOPTO huggingface dataset:
Patent SG-11201909864T-A (SG)
Title: Tcr and peptides
Inventor: BONINI MARIA CHIARA
IPC: C07K14/725
Filed: 2018-04-24
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 November 2018 (01.11.2018) WIPO I PCT 011101 Ho VIII HE ow (10) International Publication Number WO 2018/197492 Al (51) International Patent Classification: C07K 14/725 (2006.01) CO7K 14/47 (2006.01) (21) International Application Number: PCT/EP2018/060477 (22) International Filing Date: 24 April 2018 (24.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/489,226 24 April 2017 (24.04.2017) US (71) Applicants: OSPEDALE SAN RAFFAELE S.R.L. [IT/IT]; Via Olgettina 60, 20132, Milan (IT). FON- DAZIONE CENTRO SAN RAFFAELE [IT/IT]; Via 01- gettina 60, 20132, Milan (IT). (72) Inventors: BONINI, Maria Chiara; Via Olgettina 58, 20132 Milan (IT). RUGGIERO, Eliana; Via Olgettina 58, 20132 Milan (IT). MAGNANI, Zulma Irene; Via Olget- tina 58, 20132 Milan (IT). VAGO, Luca Aldo Edoardo; Via Olgettina 58, 20132 Milan (IT). BONDANZA, Attilio; Via Olgettina 58, 20132 Milan (IT). CICERI, Fabio; Via Olgettina 58, 20132 Milan (IT). (74) Agent: D YOUNG & CO LLP; 120 Holborn, London EC1N 2DY (GB). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) with sequence listing part of description (Rule 5.2(a)) N 00 O (57) : TCR AND PEPTIDES A T-cell receptor (TCR), which binds to a Wilms tumour 1 protein (WT1) peptide when presented 0 by a major histocompatibility complex (MHC). (54) Title: TCR AND PEPTIDES
Patent HU-205045-B (HU)
Title: Process and equipment for the biological-physical purification of sewages
Inventor: BAKOS TAMAS
IPC: C02F3/12
Filed: 1988-01-04
Abstract: In the process according to the invention, the waste water (effluent) - if necessary mechanically prepurified - is treated by biological trickling filter purication, if necessary aerated, flocculated and allowed to sediment, then the sedimented sludge or a part thereof - preferably mixed with waste water - with or without aeration is returned upstream of certain operations - with the exception of sedimentation - and the residual sludge and the purified water are discharged from the process. The process is characterised in that the flocculation is carried out, separately from the other operations with respect to time and place, up to a period of 5-30 minutes, preferably 15-20 minutes, at an average velocity gradient of 10-70 s<-1>, preferably 20-50 s<-1>, and furthermore the waste water and/or the sludge are/is aerated for a period of 5-40 minutes, preferably 10-15 minutes, based on the inflowing waste water rate. The process is characterised according to the invention in that it [lacuna] purifier (1) furnished with trickling filter, if necessary aeration and sludge aeration space (2, 5) and aeration apparatus (6.2, 6.5), settler (4), if necessary recirculation circuits (18, 17.1, 17.2) for the purified waste water and/or the sedimented sludge, and upstream of the settler... Original abstract incomplete. <IMAGE>
Patent IS-2113-B (IS)
Inventor: PFLAUM ZLATKO
IPC: C07D309/30
Filed: 2001-03-15
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to  Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor  or  Penicillium  genus, some are obtained by treating the fermentation products using the methods of chemical synthesis or they are the products of total chemical synthesis.  The present invention relates to the new amine salts of HMG-CoA reductase inhibitors, the preparation thereof, the preparation of pure HMG-CoA reductase inhibitors via amine salts thereof, the use of the amine salts of HMG-CoA reductase inhibitors in the process for semisynthetic preparation of HMG-CoA reductase inhibitors, the use of the amine salts of HMG-CoA reductase inhibitors in the process for biotechnological modification of HMG-CoA reductase inhibitors as well as the conversion of the amine salts of HMG-CoA reductase inhibitors into the pharmaceutically acceptable salts of the HMG-CoA reductase inhibitors and the conversion of the amine salts of HMG-CoA reductase inhibitors into the HMG-CoA reductase inhibitors in the lactone form.
Patent AT-398729-B (AT)
Inventor: LUX FRIEDRICH DIPL ING
IPC: B60C11/00
Filed: 1990-04-25
Granted: 1995-01-25
Abstract: The vehicle pneumatic tyre has a tread profile which is composed of a sequence of identical profile elements (base pitches). Base pitches with at least three different circumferential lengths are used. Groove pitches are assigned to the base pitches, the number of different groove pitch lengths being at least two and less than the number of different base pitch lengths.
Patent DK-162431-B (DK)
Inventor: WELBOURNE MICHAEL CHARLES
IPC: B07B7/083
Filed: 1985-01-11
Abstract: A classifier has a rotor 14, driven by motor 15, mounted between two opposed walls 32, 34 of housing 10. The housing 10 also has a curved wall 30 which extends between the walls 32, 34 and around the rotor 14 to define therewith an annular zone 50. A fluid and finer particles outlet opening 20 is provided in one of the walls 32, 34. The curved wall 30 has an inlet opening (16) for at least fluid and fluid and coarser particles outlet opening (18) which is registered with the inlet opening of a receptacle 12 from which the coarser particles can be removed. A plate 56 is located immediately upstream of the outlet opening (18) to divert particles adjacent to the curved wall 30 away therefrom. Similar diverting means can be located remote from the plate 56 such as plate 58 or secondary air inlet openings (64). Baffle rings 60, 62 are provided concentrically with the rotor 14 to restrain particles forced to the outer peripheries of the annular zone 50 from moving inwardly towards the rotor 14.
Patent DK-165257-B (DK)
Title: Shuttering plate
Inventor: BADSTIEBER JOHANN
IPC: E04G9/02
Filed: 1991-02-28
Abstract: PCT No. PCT/DE89/00654 Sec. 371 Date May 13, 1991 Sec. 102(e) Date May 13, 1991 PCT Filed Oct. 14, 1989 PCT Pub. No. WO90/05224 PCT Pub. Date May 17, 1990.A formwork panel has a face plate which is mounted on a frame made up of structural shapes. The panel is reinforced by a set of spaced, parallel reinforcing beams mounted on the back of the face plate. Additional beams are disposed between selected pairs of reinforcing beams. The additional beams are perpendicular to the reinforcing beams and are spaced from the frame. Each additional beam is provided with an opening which registers with a corresponding opening in the face plate. The registering openings receive tie rods which connect two facing formwork panels to one another so as to define a pouring space for concrete.
Patent HU-186382-B (HU)
Inventor: ECKERT THEODOR
Filed: 1981-02-26
Abstract: A találmány tárgya eljárás az o-(2,6-diklór-anilino)-fenil-ecetsav, az [l-(p-klór-benzoil)-5-metoxi-2-metiI-3-indolilj-ecetsav és a 2-(6-metoxi-2-naftil)-propionsav új ammóniumsóinak valamely Illb általános képletű aminnal való előállítására. A találmány szerinti eljárást az jellemzi, hogy vala- mely megfelelő alkánkarbonsav a fentiekben felsorolt ammóniumsóitól eltérő bázissal képezett sóját egy (Illb) általános képletű aminnak vagy savaddíciós sójának legalább ekvimoláris mennyiségével reagáltatunk. Az (I) általános képletű vegyületek helyileg alkalmazható gyulladásellenes és/vagy fájdalomcsillapító szerként használhatók. 186382  N «5 (Illb)  -1-
Patent HU-200139-B (HU)
Title: Process for treating liquiedes and slimes containing organic materials harmful for the environment
Inventor: TOEROEK GABOR
IPC: C02F1/52
Filed: 1987-02-19
Abstract: A treatment of effluents and sludges contaminated by organic pollutants results in easily sepd. harmless solid and liquid phases. Contaminants comprise mineral oils and their derivs. (as spent oil, emulsions, lubricating oils and greases, gas and fuel oils, or sand and soil contaminated by them), or animal/vegetable fat prodn. and tannings byproducts. During treatment, effluents and sludges contg. differing contaminants are mixed to contain max of 10 wt.% solids and 30 wt.% of organic matter. pH is set to 7.5-9; solids may be adjusted by sand or oily sludge and following cpds. are added: to the mix under intermediate agitation (all pts.wt.): 1-10 building cement, 1-10 aluminium-sulphate, 0.1-1.0 iron-chloride-sulphate, 0.1-1.0 sodium-acrylate, 0.001-0.01 anionic polymer and finally 0.001-0.01 yeast. Agitation is continued for approx. 10 mins. depending on the temp. of the mixt. and pH is set to 6.8-6.9. - The phases are sepd. and water obtd. during solid phase dewatering can be reused for dilution of consecutive batches.
Patent HU-183862-B (HU)
Inventor: BOROS ARPAD
IPC: E05B15/02
Filed: 1982-03-23
Abstract: A találmány tárgya lengőajtó, amely vonalban függesztett rugalmas ajtólappal(okkal) rendelkezik, továbbá a lengőajtó helybentartásához ill. visszatérítéséhez szükséges rugós mechanizmus(ok) a vízszintes tartókeret(ek)ben van(nak) elhelyezve, míg a rugalmas ajtólap(ok) a függőleges tartókeret(ek) vagy a vízszintes tartókeret(ek) fészkében van(nak) megvezetve. A találmánynak az a lényege, hogy a vízszintes tartókeretek) és/vagy függőleges tartókeret(ek) tok felé eső része legalább 180 °-os ívben .hengeres kialakítású. A függőleges vagy vízszintes tartókeret(ek) keretprofilja hengeres részének tengelye egybeesik a lengőajtó rugalmas ajtólapjá(ai)nak forgási középvonalával.  -1-
Patent HU-192679-B (HU)
Inventor: KOPASZ JANOS
IPC: H05K7/20
Filed: 1985-03-12
Abstract: A találmány tárgya elrendezés műszervagy készülékváz, illetve vázrendszer hőelvezetésének mechanikus szerkezeli elemekkel történő kialakítására, különösen zártpalástú modulár rack rendszerű elektronikus alkatrészeket tartalmazó műszerekhez vagy készülékekhez, amely vázban hőforrást jelentő elektronikus alkatrészek vannak. A találmánynak az a lényege, hogy az egy egységet képező elektronikus alkatrészeket hordozó eszközök, pl. kártyák (7) között illetve mellett böfelvevő és hővezető lemezek (8) illetve bordák, előnyösen árnyékoló és/vagy hordozs és/vagy merevítő lemezek illetve bordák vunnak elhelyezve, amely hővezető lemezek (8) illetve bordák a vázat burkoló külső szabad felületekhez belülről közvetlenül agy közvetve csatlakozóan vannak elrer.d· zve. (1. ábra)  192679 -1-
Patent LT-3367-B (LT)
Title: Hepatitis b virus surface proteins with reduced host carbohydrate content
Inventor: KNISKERN PETER J
IPC: C07K14/02
Filed: 1993-03-30
Abstract: In order to produce hepatitis B virus (HBV) surface proteins in the form of particles with substantially reduced entrapped carbohydrate content, DNA encoding the HBV surface proteins was expressed in a recombinant yeast host which is deficient in its ability to glycosylate proteins. These HBV surface proteins display the antigenic sites genetically encoded by the S domain of the HBV virion envelope open reading frame and contains substantially reduced levels of entrapped carbohydrate when compared with HBsAg particles produced in "wild-type" yeast cells. These particles are useful as a vaccine for both the active and passive treatment or prevention of disease and/or infection caused by HBV or other agents serologically related to HBV. <IMAGE>
Patent LT-3521-B (LT)
Title: Methods for weeds control
Inventor: MOON MARCUS P
IPC: A01N47/36
Filed: 1993-06-23
Abstract: Compounds of the formula <CHEM>  wherein R is C1-C4 alkyl, CH2CH=CH2, CH2C IDENTICAL CH, cyclopropylmethyl or CH2CH2R2; R1 is C1-C2 alkyl, C1-C2 haloalkyl, CH2CN, CH2OCH3, C1-C3 alkoxy, C1-C3 alkylthio, phenylthio or NR3R4;  R2 is C1-C2 alkoxy, C1-C2 alkylthio, CN or halogen;  R3 and R4 are independently H or CH3; and  X is NHCH3, N(CH3)2 or N(CH3)OCH3; provided that when R1 is OCH2CH3 or CH2OCH3, then R is other than CH3; and their agriculturally suitable salts. exhibit herbicidal activity. They have particular utility for the selective control of weeds in beet.
Patent YU-49460-B (YU)
Inventor: BIGOVIC DUBRAVKA
IPC: A61K45/06
Filed: 1996-04-11
Abstract: Hemoterapeutik za primenu u veterini, naznačen time, što predstavlja smešu oksitetraciklon hidrohlorida i sulfadimidina čiji je odnos 0,5 : 1,5 do 1,5 : 2,75, kojoj je dodat neomicin sulfat, u količlnama 2 Гѓ 106 do 5 Гѓ 106 I.J., a koja, kao nosač, sadrži ugljeni hidrat u količini do 80% računajući na ukupnu količinu preparata. Prijava sadrži još 2 zavisna patentna zahteva.
Patent YU-44688-B (YU)
Title: Elastic joint, clasp and similar
Inventor: BRENNER H
IPC: F16F1/393
Filed: 1985-05-27
Abstract: The invention provides an elastic articulated coupling which comprises a relatively rigid inner member having a longitudinal axis, a relatively rigid outer member having a generally cylindrical interior of a predetermined first diameter surrounding said inner member with substantial clearance, and an elastomeric body located in the clearance between the inner and outer members. The elastomeric body is connected firmly to the inner member. Additionally, a sleeve comprising wear-resistant elastic material is firmly connected to the elastomeric body and disposed between the elastomeric body and the outer member. The elastomeric body and the sleeve together have a predetermined second diameter which is greater than the predetermined first diameter defined by the interior of the generally cylindrical outer member. As a result, the sleeve is connected in a non-positive manner with the interior surface of the outer member merely by radial pre-stressing and by axial bracing.
Patent ZA-89898-B (ZA)
Title: Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
Inventor: DIRLAM JOHN PHILIP
IPC: A61K35/74
Filed: 1989-02-06
Abstract: An acidic polycyclic ether antibiotic, having structure established by X-ray crystallography, is formed by fermentation of a novel microorganism, Actinomadura sp. ATCC 53708. This novel antibiotic is useful as an anticoccidial in chickens, in the prevention or treatment of swine dysentery, and as a growth promotant in cattle and swine.
Patent ZA-91840-B (ZA)
Title: A method for the chlorine-free bleaching of dissolving pulps
Inventor: HRUSCHKA ANTON
IPC: D21C9/153
Filed: 1991-02-05
Abstract: The process comprises three stages, namely an oxygen bleach which is optionally combined with a hydrogen peroxide bleach (EOP stage), an ozone bleach (Z stage) and a peroxide bleach (P stage). According to the invention, the residual oxygen content of the exit air from the Z stage is completely reacted in the EOP stage, and the effluent of the Z stage is used for dilution between the EOP and Z stages and/or for ash removal from the pulp after bleaching. It is advantageous in this case to control the temperature, the NaOH supply and the O2/H2O2 ratio in the EOP stage, so that the oxygen consumption at a constant conversion is adjusted to the residual oxygen content of the exit air from the Z stage.
Patent AT-408250-B (AT)
Title: Method for operating a two-stroke internal combustion engine and two-stroke internal combustion engine
IPC: F02D3/00
Filed: 1985-04-29
Granted: 2001-09-25
Abstract: What is described is a method for operating a two-stroke internal combustion engine with at least one working cylinder 1 which is controlled via the air quantity supplied and via the fuel quantity injected per work cycle, fuel injection being periodically interrupted in the part-load range for individual work cycles. In order to afford advantageous method conditions, it is proposed that the period of the interruptions in fuel injection be selected as a function of the air quantities and fuel quantities determined in each case by the control <IMAGE>
Patent AT-393852-B (AT)
Title: Process and apparatus for exchanging the pressurized liquid medium in a flat jack by a curing material
IPC: E01D21/06
Filed: 1986-05-23
Granted: 1991-12-27
Abstract: In a process and an apparatus for exchanging the pressurized liquid medium in a flat jack by a curing material, the apparatus comprises a hydraulic cylinder 6, which is subdivided into two cylinder spaces 6', 6''. The pistons 7, 8 of each cylinder space are connected by a piston rod 9. Each cylinder space is thereby subdivided into a right-hand chamber 13, 14 and a left-hand chamber 11, 12. Mortar is introduced into the left-hand chamber 11 of the first cylinder space 6', while the right-hand chamber 13 is filled with the same liquid medium that is present in the flat jack 1. The right-hand chamber 14 of the second cylinder space 6'' is filled with a hydraulic fluid. A first pump 26 is used to increase the pressure in the first cylinder space 6' up to the pressure in the flat jack 1. A second pump 30 is used to displace the pistons 7, 8, so that the mortar is forced into the flat jack 1 and the liquid medium is discharged. <IMAGE>
Patent AT-399434-B (AT)
Title: Method and apparatus for generating an oscillation having a transmission frequency
Inventor: TSCHIRK WOLFGANG MAG
IPC: H03J7/02
Filed: 1988-09-29
Granted: 1995-05-26
Abstract: According to GSM Recommendation 5.10, a carrier frequency accuracy of 0.1 ppm is required for a mobile telephone in the D network (GSM network). A sinusoidal pulse (PSW burst) having a corresponding frequency is transmitted at periodic intervals by the base station. In the mobile telephone, a digital signal processor SP with a sine generator SIG adaptively matches the frequency of a generated oscillation to the frequency of this reference signal in such a way that the expected value of the square of the difference between the corresponding reference values rw of the reference signal and a generated value gw becomes a minimum. The start approximation of the generated value gw is calculated from amplitude A0, phase α0 and start value ω0 for the transmission frequency ω. The transmission frequency ω is adapted iteratively to the frequency of the reference signal using the generated values gw. <IMAGE>
Patent AT-401370-B (AT)
Inventor: DROSG WOLFGANG DIPL ING
IPC: B60C11/04
Filed: 1992-12-24
Granted: 1996-08-26
Abstract: Pneumatic vehicle tyre with a tread profile which is divided by grooves or channels into profile elements such as profile blocks and/or profile belts, profile elements being provided with fine lamina indents which are connected to venting grooves which run at least essentially in the circumferential direction. The venting grooves (11, 11', 13) follow, viewed from above, a curve which is composed at least in certain sections of one or more curves of a second or higher order. <IMAGE>
Patent DK-149092-B (DK)
Inventor: GOLDSTEIN GIDEON
IPC: A61P43/00
Filed: 1980-03-13
Abstract: There are disclosed new biological active polypeptides:wherein A is deamino-LYS or LYS; X is a suitable neutral aliphatic amino acid residue; e.g., one selected from the group consisting of SER, ALA, 2-Me-ALA, GLY, LEU, THR, D-SER, D-ALA, D-THR, allo-THR, D-LEU, and SAR; B is GLN-R', decarboxy-GLN, orand R' is a substituent which does not substantially affect the biological activity of the tripeptide.These polypeptides have the capability of inducing the differentiation of T lymphocytes as measured by the acquisition of the thymic differentiation antigen Th-I, as well as B-lymphocytes as measured by the acquisition of the differentiation antigen Bu-i. The polypeptides are thus useful in thymic function and immunity areas such as in treatment for congenital absence of thymus. Also provided are therapeutic compositions and methods for use of the polypeptides.
Patent DK-164281-B (DK)
Inventor: GALL RUDI
IPC: C07F9/38
Filed: 1988-03-01
Abstract: The present invention provides disphosphonates of the general formula:   <IMAGE> (I)  wherein R1 is a straight-chain or branched, saturated or unsaturated aliphatic hydrocarbon radical of 1-9 carbon atoms which is optionally substituted by phenyl or cyclohexyl, R2 is cyclohexyl or cyclohexylmethyl, benzyl or a straight-chained or branched, saturated or unsaturated aliphatic hydrocarbon of 4 to 18 carbon atoms which is optionally substituted by phenyl or oxygen wherein the oxygen can be esterified or etherified, R3 is hydrogen or a straight-chain or branched alkyl of 1-4 carbon atoms, X is a straight-chain or branched alkylene chain of 1-6 carbon atoms and Y is hydrogen, hydroxyl or an amino group optionally substituted by alkyl radicals of 1-6 carbon atoms; as well as the pharmacologically acceptable salts thereof. The present invention also provides processes for the preparation of these diphosphonic acid derivatives and pharmaceutical compositions containing them for the prophyllaxis treatment of diseases or disturbances of calcium metabolism such as osteoporsis, Pagets disease, Bechterew's disease, bone metastases, urolithiasis, heterotropic ossifications, rheumatoid arthritis, osteoarthritis and degenerative arthrosis.
Patent DK-159440-B (DK)
Inventor: HARRISON BOYD LYNN
IPC: C07D339/06
Filed: 1983-04-11
Abstract: N-(1-3-dithiolan-2-ylidene)-4-alkylanilines having a hydroxy, alkoxy or alkanoyloxy substituent on the alkyl group are useful as anti-inflammatory agents, as analgesic agents and as antiasthmatic agents. The compounds involved can be prepared by the reaction of an appropriate 4-alkylaniline with a methyl(1,3-dithiolan-2-ylidene)sulfonium salt or with carbon disulfide and ethylene dibromide in the presence of a base.
Patent DK-163375-B (DK)
Inventor: MEINIG MANFRED
IPC: F16L23/00
Filed: 1986-05-01
Abstract: A one-piece flange ring for mounting in an open pipe includes a flange, an outer and an inner leg projecting from the flange, and an outer and an inner annularly projecting land for engaging the inner wall of the pipe. The outer leg is closer to the inner wall of the pipe than the inner leg when installed in the pipe. The outer and the inner leg are substantially parallel to one another and a capable of being fixed under stress with respect to the flange by the inner wall of the pipe when the legs are driven into the open pipe. The outer and the inner pipe engaging lands have an outer diameter greater than the inner diameter of the pipe before installation in the pipe, and they are flexed under stress toward the center of the pipe when the flange ring is installed in the pipe. The outer and the inner pipe engaging lands have an outer diameter equal to the inner diameter of the pipe after installation in the pipe. The outer and the inner pipe engaging lands are bent diagonally toward the flange. The flange includes two parallel faces, an outer face and an inner face. The outer face projects substantially perpendiculary from the outer leg. The inner face projects substantially perpendiculary from the inner leg.